Handa Pharmaceuticals, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced total revenue was TWD 84.070 million compared to TWD 93.690 million a year ago. Operating loss was TWD 204.940 million compared to TWD 198.735 million a year ago. Net loss was TWD 177.739 million compared to TWD 166.507 million a year ago. Basic loss per share was TWD 1.62 compared to TWD 1.59 a year ago.